Dyskeratosis Congenita Clinical Trial
Official title:
Clinical Care Consortium of Telomere-Associated Ailments (CCCTAA) Database
Study Description: This protocol will be utilized for the creation and management of a repository of coded clinical data on patients with Telomere Biology Disorders (TBDs) submitted by researchers from CCCTAA member institutions. Objective: The primary objective of this study is to develop a shared database (repository) of coded clinical research data, managed by NCI, to facilitate collaborative research across CCCTAA member institutions.
Study Description: This protocol will be utilized for the creation and management of a repository of coded clinical data on patients with Telomere Biology Disorders (TBDs) submitted by researchers from CCCTAA member institutions. Objective: The primary objective of this study is to develop a shared database (repository) of coded clinical research data, managed by NCI, to facilitate collaborative research across CCCTAA member institutions. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04959188 -
Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
|
||
Recruiting |
NCT04638517 -
The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis
|
Phase 2 | |
Recruiting |
NCT00027274 -
Cancer in Inherited Bone Marrow Failure Syndromes
|
||
Terminated |
NCT01001598 -
Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita
|
Phase 1/Phase 2 | |
Recruiting |
NCT03579875 -
Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
|
Phase 2 | |
Recruiting |
NCT02720679 -
Investigation of the Genetics of Hematologic Diseases
|
||
Active, not recruiting |
NCT01659606 -
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
|
Phase 2 | |
Completed |
NCT00499070 -
Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
|
N/A | |
Recruiting |
NCT02162420 -
Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
|
N/A | |
Completed |
NCT00004787 -
Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes
|
Phase 2 | |
Completed |
NCT00455312 -
Stem Cell Transplant (SCT) for Dyskeratosis Congenita or SAA
|
Phase 2/Phase 3 | |
Recruiting |
NCT03050268 -
Familial Investigations of Childhood Cancer Predisposition
|